By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company EOM Pharmaceuticals Holdings, Inc.

EOM Pharmaceuticals Holdings, Inc. (IMUC)

OTC Currency in USD
$0.07
+$0.01
+14.02%
Last Update: 3 Sept 2025, 18:42
$7.88M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.01 - $0.21
52 Week Range

IMUC Stock Price Chart

Explore EOM Pharmaceuticals Holdings, Inc. interactive price chart. Choose custom timeframes to analyze IMUC price movements and trends.

IMUC Company Profile

Discover essential business fundamentals and corporate details for EOM Pharmaceuticals Holdings, Inc. (IMUC) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

8 Jan 2021

Employees

3.00

CEO

Irach B. Taraporewala

Description

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.

IMUC Financial Timeline

Browse a chronological timeline of EOM Pharmaceuticals Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Stock split effective on 16 Sept 2020

Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.

IMUC Stock Performance

Access detailed IMUC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run